Ted L. Underiner

944 total citations
31 papers, 763 citations indexed

About

Ted L. Underiner is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Ted L. Underiner has authored 31 papers receiving a total of 763 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Organic Chemistry and 8 papers in Oncology. Recurrent topics in Ted L. Underiner's work include Angiogenesis and VEGF in Cancer (5 papers), Chemical Synthesis and Analysis (4 papers) and Liver physiology and pathology (4 papers). Ted L. Underiner is often cited by papers focused on Angiogenesis and VEGF in Cancer (5 papers), Chemical Synthesis and Analysis (4 papers) and Liver physiology and pathology (4 papers). Ted L. Underiner collaborates with scholars based in United States and France. Ted L. Underiner's co-authors include Harlan L. Goering, Sheila Miknyoczki, Torsten Herbertz, Xavier Creary, Thelma S. Angeles, Mark S. Albom, Bruce D. Dorsey, Bruce Ruggeri, Allan M. Ferguson and David E. Patterson and has published in prestigious journals such as Journal of the American Chemical Society, Blood and Journal of Medicinal Chemistry.

In The Last Decade

Ted L. Underiner

31 papers receiving 712 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ted L. Underiner United States	18	388	331	154	100	96	31	763
Jae Du Ha South Korea	21	636 1.6×	555 1.7×	234 1.5×	57 0.6×	94 1.0×	53	1.2k
Gregory R. Ott United States	20	462 1.2×	492 1.5×	172 1.1×	60 0.6×	163 1.7×	34	948
Ulrich Grädler Germany	17	616 1.6×	180 0.5×	125 0.8×	47 0.5×	80 0.8×	28	987
Robert A. Galemmo United States	19	494 1.3×	262 0.8×	158 1.0×	26 0.3×	33 0.3×	46	1.0k
Mark J. Mulvihill United States	21	863 2.2×	536 1.6×	252 1.6×	65 0.7×	113 1.2×	49	1.5k
Todd Miller United States	4	267 0.7×	179 0.5×	139 0.9×	47 0.5×	107 1.1×	6	547
Joachim Blanz Germany	14	536 1.4×	183 0.6×	202 1.3×	89 0.9×	98 1.0×	31	967
Vito Guagnano Switzerland	16	896 2.3×	343 1.0×	380 2.5×	105 1.1×	135 1.4×	30	1.4k
Wufu Zhu China	24	544 1.4×	727 2.2×	153 1.0×	122 1.2×	139 1.4×	53	1.1k
Nozomu Koyanagi Japan	12	614 1.6×	571 1.7×	247 1.6×	25 0.3×	38 0.4×	18	1.0k

Countries citing papers authored by Ted L. Underiner

Since Specialization

Citations

This map shows the geographic impact of Ted L. Underiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ted L. Underiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ted L. Underiner more than expected).

Fields of papers citing papers by Ted L. Underiner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ted L. Underiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ted L. Underiner. The network helps show where Ted L. Underiner may publish in the future.

Co-authorship network of co-authors of Ted L. Underiner

This figure shows the co-authorship network connecting the top 25 collaborators of Ted L. Underiner. A scholar is included among the top collaborators of Ted L. Underiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ted L. Underiner. Ted L. Underiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qian, Jie, Beverly P. Holskin, Jay Theroff, et al.. (2012). Improvement of Inhibitor Identification for Heat Shock Protein 90α by Utilizing a Red-Shifted Fluorescence Polarization Probe. Assay and Drug Development Technologies. 10(4). 375–381. 1 indexed citations

Zificsak, Craig A., Jay Theroff, Lisa D. Aimone, et al.. (2011). Methanesulfonamido-cyclohexylamine derivatives of 2,4-diaminopyrimidine as potent ALK inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(13). 3877–3880. 18 indexed citations

Albom, Mark S., Thelma S. Angeles, Henry J. Breslin, et al.. (2011). 2,7-Pyrrolo[2,1-f][1,2,4]triazines as JAK2 inhibitors: Modification of target structure to minimize reactive metabolite formation. Bioorganic & Medicinal Chemistry Letters. 21(24). 7325–7330. 17 indexed citations

Zificsak, Craig A., Diane E. Gingrich, Henry J. Breslin, et al.. (2011). Optimization of a novel kinase inhibitor scaffold for the dual inhibition of JAK2 and FAK kinases. Bioorganic & Medicinal Chemistry Letters. 22(1). 133–137. 18 indexed citations

Hudkins, Robert L., Allison L. Zulli, Ted L. Underiner, et al.. (2011). Synthesis and Biological Profile of the pan-Vascular Endothelial Growth Factor Receptor/Tyrosine Kinase with Immunoglobulin and Epidermal Growth Factor-Like Homology Domains 2 (VEGF-R/TIE-2) Inhibitor 11-(2-Methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one (CEP-11981): A Novel Oncology Therapeutic Agent. Journal of Medicinal Chemistry. 55(2). 903–913. 38 indexed citations

Milkiewicz, Karen L., Lisa D. Aimone, Mark S. Albom, et al.. (2011). Improvement in oral bioavailability of 2,4-diaminopyrimidine c-Met inhibitors by incorporation of a 3-amidobenzazepin-2-one group. Bioorganic & Medicinal Chemistry. 19(21). 6274–6284. 11 indexed citations

Albom, Mark S., Thelma S. Angeles, Jean Husten, et al.. (2010). Fused bicyclic derivatives of 2,4-diaminopyrimidine as c-Met inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(1). 164–167. 22 indexed citations

Zificsak, Craig A., Jay Theroff, Lisa D. Aimone, et al.. (2010). 2,4-Diaminopyrimidine inhibitors of c-Met kinase bearing benzoxazepine anilines. Bioorganic & Medicinal Chemistry Letters. 21(2). 660–663. 13 indexed citations

Underiner, Ted L., Torsten Herbertz, & Sheila Miknyoczki. (2010). Discovery of Small Molecule c-Met Inhibitors: Evolution and Profiles of Clinical Candidates. Anti-Cancer Agents in Medicinal Chemistry. 10(1). 7–27. 121 indexed citations

10.

Hudkins, Robert L., Allison L. Zulli, Ted L. Underiner, et al.. (2010). 8-THP-DHI analogs as potent Type I dual TIE-2/VEGF-R2 receptor tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(11). 3356–3360. 9 indexed citations

11.

Milkiewicz, Karen L., Mark S. Albom, Thelma S. Angeles, et al.. (2010). Synthesis and structure–activity relationships of 1,2,3,4-tetrahydropyrido[2,3-b]pyrazines as potent and selective inhibitors of the anaplastic lymphoma kinase. Bioorganic & Medicinal Chemistry. 18(12). 4351–4362. 20 indexed citations

12.

Underiner, Ted L., Bruce Ruggeri, Lisa D. Aimone, et al.. (2008). TIE-2/VEGF-R2 SAR and in vitro activity of C3-acyl dihydroindazolo[5,4-a]pyrrolo[3,4-c]carbazole analogs. Bioorganic & Medicinal Chemistry Letters. 18(7). 2368–2372. 8 indexed citations

13.

Zulli, Allison L., Edward R. Bacon, Ted L. Underiner, et al.. (2008). Design and synthesis of dihydroindazolo[5,4-a]pyrrolo[3,4-c]carbazole oximes as potent dual inhibitors of TIE-2 and VEGF-R2 receptor tyrosine kinases. Bioorganic & Medicinal Chemistry Letters. 18(6). 1916–1921. 15 indexed citations

14.

Ruggeri, Bruce, Ted L. Underiner, Diane E. Gingrich, et al.. (2007). CEP-11981: A potent TIE-2/Pan-VEGF-R inhibitor with broad kinase inhibitory activity exhibits significant antitumor and antiangiogenic efficacy in preclinical tumor models. Molecular Cancer Therapeutics. 6. 2 indexed citations

15.

Wan, Weihua, Mark S. Albom, Lihui Lü, et al.. (2005). Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cells. Blood. 107(4). 1617–1623. 85 indexed citations

16.

Raulli, Robert, Paul Actor, Ted L. Underiner, et al.. (2003). CT2108A and B: New Fatty Acid Synthase Inhibitors as Antifungal Agents. Journal of Natural Products. 66(8). 1041–1046. 25 indexed citations

17.

Paquette, Leo A., et al.. (1997). First Synthesis of Cytotoxic 8,9-Secokaurene Diterpenoids. An Enantioselective Route to (−)-O-Methylshikoccin and (+)-O-Methylepoxyshikoccin. Journal of the American Chemical Society. 119(41). 9662–9671. 26 indexed citations

18.

Underiner, Ted L. & Harlan L. Goering. (1990). Cross coupling of allylic derivatives. 16. Regiochemistry of cross coupling of the isomeric (E,E)-3,5-heptadien-2-yl and (E,E)-2,5-heptadien-4-yl pivalates with organocopper and Grignard reagents. The Journal of Organic Chemistry. 55(9). 2757–2761. 19 indexed citations

19.

Underiner, Ted L. & Harlan L. Goering. (1989). Cross coupling of allylic derivatives. 15. Regio- and stereospecfic cross-coupling reactions of dienyl allylic N-phenylcarbamates with phenylcopper reagents. The Journal of Organic Chemistry. 54(13). 3239–3240. 6 indexed citations

20.

Underiner, Ted L., et al.. (1989). Alkylation of allylic derivatives. 14. Relationship of double-bond configuration between reactant and product for cross-coupling reactions of Z-allylic carboxylates with organocopper reagents. The Journal of Organic Chemistry. 54(10). 2369–2374. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact